SCHEMBL4299059

SCHEMBL4299059

COC(=O)CNC(=O)c1cc(Br)c(Oc2ccc3[nH]c(C(F)(F)C(F)F)nc3c2)c(Br)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
GAA P10253 1/20 0.37
ALDH1A1 P00352 3/20 0.35
HTT P42858 3/20 0.35
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPK1 P28482 1/20 0.34
ABL1 P00519 1/20 0.34
KMT2A Q03164 2/20 0.33
TRPV1 Q8NER1 2/20 0.33
RAB9A P51151 2/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
THRB P10828 3/20 0.32
THRA P10827 2/20 0.32
HPGDS O60760 1/20 0.32
STAMBP O95630 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4295275 0.92 ATM (0.38) ABL1EGLN1THRBTHRA
SCHEMBL3980253 0.81 EGLN1 (0.40) EGLN1THRBTHRA
SCHEMBL3978301 0.81 THRB (0.37) KMT2AMEN1THRBTHRA
SCHEMBL3986363 0.78 THRB (0.37) THRBTHRA
SCHEMBL4540014 0.75 EGLN1 (0.36) GAAEGLN1THRBTHRA
SCHEMBL3979453 0.72 THRB (0.34) KDM4EALDH1A1HTTLMNAL3MBTL1
SCHEMBL3137803 0.71 KDM4E (0.51) KDM4EGAAALDH1A1LMNAL3MBTL1
SCHEMBL3976827 0.71 THRB (0.39) KDM4EEGLN1THRBTHRASMN1; SMN2
SCHEMBL3981285 0.69 EGLN1 (0.38) EGLN1THRBTHRA
SCHEMBL3130752 0.68 GAA (0.53) KDM4EGAAALDH1A1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO claimed
US-20090318514-A1 Novel Pharmaceutical Compositions KARO BIO AB (SE) 2009-12-24 US disclosed
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318514-A1 Novel Pharmaceutical Compositions TSHR, TRHR, THRA KDM4E 1775/4885GAA 3977/4885ALDH1A1 1459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.